Financial & competing interests disclosure
GM Glenn is Chief Scientific Officer, Iomai Corporation, MD, USA. D O’Hagan is Head of Vaccine Delivery Research, Novartis Vaccines and Diagnostics, Inc., MA, USA. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.